LY3084077

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3084077, covering 2018-07-30 to 2018-07-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3084077 in Healthy Participants [Phase 1]